#7 KALI SULPH. 6X 500 Tablets

Manufacturer: Hyland's Inc.
Effective date: 2022-12-19
Label type: HUMAN OTC DRUG LABEL
Version: 4
Source: full-release
Hydrated at: 2026-06-01 02:18:59

Label at a glance#

ProductKALI SULPH

Active ingredientPOTASSIUM SULFATE

Label structure6 sections

Dosage and administration

Adults & Children ages 6 - 12: 4 tablets. Children ages 2 - 6: 2 tablets. Dissolve under tongue 3 times a day. Use more frequently (every 15 minutes for up to 8 doses) with acute conditions.

Contacts and useful links#

PhoneLabel contact800.624.9659

Label contents#

Full prescribing information#

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

Adults & Children ages 6 - 12: 4 tablets. Children ages 2 - 6: 2 tablets. Dissolve under tongue 3 times a day. Use more frequently (every 15 minutes for up to 8 doses) with acute conditions.

INDICATIONS

INDICATIONS & USAGE SECTION

OTC - PURPOSE SECTION

Relief of symptoms of the common cold. Relief of symptoms of pimples and blemishes associated with common acne.

FORMULA

OTC - ACTIVE INGREDIENT SECTION

Kali Sulphuricum 6X HPUS

INACTIVE INGREDIENT SECTION

In a base of Acacia Gum, Lactose N.F.

Warnings

WARNINGS SECTION

OTC - DO NOT USE SECTION

Do not use if imprinted cap band is broken or missing.

OTC - ASK DOCTOR SECTION

If symptoms persist for more than seven days or worsen, contact a licensed health care provider.

OTC - STOP USE SECTION

Discontinue use if symptoms are accompanied by a high fever (over 101° F).

OTC - PREGNANCY OR BREAST FEEDING SECTION

If you are pregnant or nursing, seek the advice of a licensed health care provider before using this product.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this and all medications out of the reach of children.

QUESTIONS?

OTC - QUESTIONS SECTION

800.624.9659

PRINCIPAL DISPLAY PANEL - 500 Tablet Bottle Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

HOMEOPATHIC

NDC 54973-5230-01

Hyland's^®

^#7
Kali Sulph. 6X

Colds,
Skin Eruptions

500 TABLETS

label

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
95250459-30e4-45c1-b08a-993044f49109	Product name	2	20250805
26acd337-b838-40ac-bcbc-05c3b81c8712	Product name	1	20170323

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
54973-5230-1	KALI SULPH	500 in 1 BOTTLE, PLASTIC	TABLET	500		4
54973-5230-2	KALI SULPH	1000 in 1 BOTTLE, PLASTIC	TABLET	1000		4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
54973-5230	KALI SULPH (POTASSIUM SULFATE) TABLET [HYLAND'S INC.]	4	Current NDC, Legacy NDC, 2 package rows	20221220_c00e31d8-76df-47b1-bafd-36d088395522.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
POTASSIUM SULFATE	ACTIVE INGREDIENT	1K573LC5TV	1
SULFATE ION	ACTIVE MOIETY	7IS9N8KPMG	1
ACACIA	INACTIVE INGREDIENT	5C5403N26O	1
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

KALI SULPH
potassium sulfate
ACACIA
LACTOSE
SULFATE ION

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
54973-5230	54973-5230-1, 54973-5230-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ACACIA	5C5403N26O	IACT
LACTOSE	J2B2A4N98G	IACT
POTASSIUM SULFATE	1K573LC5TV	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 6 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Match
ACACIA	ACACIA	5C5403N26O	TABLET / ORAL	70 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / ORAL	2500 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / ORAL	2500 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	TABLET / ORAL	70 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
ACACIA	ACACIA	5C5403N26O	TABLET / ORAL	70 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / ORAL	2500 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
KALI SULPH	POTASSIUM SULFATE	Hyland's Inc.	c00e31d8-76df-47b1-bafd-36d088395522	2022-12-19	Warnings	Exact identifier ndc (package): 54973-5230-2 ndc (package): 54973-5230-1 ndc (product): 54973-5230 ndc11 (package): 54973523002 ndc11 (package): 54973523001 spl id: f0330ffb-503d-2671-e053-2995a90a8218 spl set id: c00e31d8-76df-47b1-bafd-36d088395522

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.